| Dr Shamsi Lashgari-saegh, MD | |
|
10701 East Blvd, Cleveland, OH 44106-1702 | |
| (216) 791-3800 | |
| Not Available |
| Full Name | Dr Shamsi Lashgari-saegh |
|---|---|
| Gender | Female |
| Speciality | Physical Medicine & Rehabilitation - Spinal Cord Injury Medicine |
| Location | 10701 East Blvd, Cleveland, Ohio |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144399635 | NPI | - | NPPES |
| 0474231 | Medicaid | OH | |
| 341366773-00 | Other | OH | WORKMAN'S COMPENSATION |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2081P0004X | Physical Medicine & Rehabilitation - Spinal Cord Injury Medicine | 35045660 (Ohio) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Shamsi Lashgari-saegh, MD 10701 East Blvd, Cleveland, OH 44106-1702 Ph: (216) 791-3800 | Dr Shamsi Lashgari-saegh, MD 10701 East Blvd, Cleveland, OH 44106-1702 Ph: (216) 791-3800 |
News Archive
Lilly released results today from a Phase II study evaluating Lilly Oncology's tasisulam, a novel anti-cancer agent, in patients with metastatic melanoma, the deadliest form of skin cancer. Study results will be presented during the 46th Annual Meeting of the American Society of Clinical Oncology (ASCO) held in Chicago, Ill. on June 6, 2010.
USANA Health Sciences, Inc. today announced it has obtained the U.S. Food and Drug Administration's "Drug Establishment Registration," allowing the company to manufacture over-the-counter (OTC) drugs and holding it to a standard well above what is required of a dietary supplement manufacturer.
A simple recipe—including just four ingredients—can transform adult human skin cells into cells that resemble embryonic stem cells, researchers report in an immediate early publication of the journal Cell, a publication of Cell Press.
GenSpera, Inc. announced that the Medicines and Healthcare products Regulatory Agency (MHRA) of the United Kingdom (UK) has cleared for initiation a Phase II human clinical trial of its lead compound, G-202, in the treatment of prostate cancer patients who have failed prior hormonal therapy.
› Verified 5 days ago
Dr. Sultan Zaidan, Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 18780 Bagley Rd # 100, Cleveland, OH 44130 Phone: 440-816-2850 Fax: 440-816-2855 | |
Dr. Robert Edwin Moore, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 2500 Metrohealth Dr, Cleveland, OH 44109 Phone: 216-778-3207 | |
Michael P Schaefer, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: Cleveland Clinic Foundation Orthopedics A40, 9500 Euclid Avenue, Cleveland, OH 44195 Phone: 216-444-0851 | |
Dr. Renae R Fisher, MD Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 10701 East Blvd, Cleveland, OH 44106 Phone: 216-791-3800 | |
Devon Brooke Mclennan, MD Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 2500 Metrohealth Dr, Cleveland, OH 44109 Phone: 216-778-7800 | |
Marzena M Buzanowska, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 9500 Euclid Ave, Desk S40, Cleveland, OH 44195 Phone: 216-444-6077 | |
Dr. Jack E Kelly, PT, DPT Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 10701 East Blvd, Cleveland, OH 44106 Phone: 216-791-3800 |